GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CHRM1, CHRM3, CYP19A1, CYP1A1, CYP1B1, DRD3, EGFR, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOA, MET, MIF, POLA1, POLB, PPARA, PRKCD, SMAD3, SRC, TEK, TRPV1, XDH |
11.6113 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, FABP3, FABP4, FUT7, HSD11B1, HSD17B1, HSD17B2, KIT, MET, MIF, PPARA, PTGES, TBXAS1, TRPV1 |
11.6113 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, TYR, XDH |
11.5431 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
11.5431 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
11.5339 |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
11.272 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, POLB, PPARA, PRKCD, PTGES, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
10.8363 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, AKR1B10, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TYR |
10.6432 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3708 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, FUT7, GLO1, HSPA1A, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR, XDH |
9.60386 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, APP, AXL, BCL2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, FABP3, HSD17B2, IGF1R, INSR, MMP2, MMP9, POLB, PPARA, PRKCD, PTGES, RORC, SRC, TEK, TRPV1, TYR |
9.54466 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
9.44175 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
9.44175 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, APP, BCL2, CDC25B, CHRM1, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, PIM1, PTGES, SMAD3, SRC, TEK, XDH |
9.44175 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
9.12928 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, EGFR, FABP4, KDR, KIT, MMP9, PRKCD, PTGES, SRC |
9.09731 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, NUAK1, PRKCD, PTPN1, SRC, TEK, XDH |
9.06292 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, POLB, PPARA, PRKCD, PTGES, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
9.05221 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CSNK2A1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TRPV1 |
9.01569 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
8.9885 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CYP1B1, EGFR, ERBB2, F10, F3, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, PTPN1, SRC, TEK, XDH |
8.95248 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, APP, BCL2, CHRM1, CYP19A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK |
8.89197 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.8237 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
8.81891 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP2, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
8.62503 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ERBB2, FABP3, FLT3, IGF1R, INSR, KIT, MMP2, PPARA, PRKCD, SMAD3, SRC, TEK, TRPV1 |
8.07745 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, APP, BCL2, CACNA1C, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK |
8.0323 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
7.89907 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, ERBB2, F10, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK |
7.85232 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
7.83827 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CHRM1, CHRM3, CHRM5, CYP1A1, EGFR, ERBB2, FLT3, KIT, MET, MIF, PIM1, POLA1, PRKCD, SRC, TEK, TYR |
7.81774 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA6, CA9, CHRM2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, TYR |
7.81774 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CDC25B, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B2, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PIM1, POLB, PPARA, PRKCD, RORC, SMAD3, SRC, TEK, TOP2A, TYR |
7.79031 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, PIM1, SRC, TEK |
7.69211 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
7.62156 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK |
7.61338 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CACNA1C, CHRM1, CHRM3, CHRM5, CYP19A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, F10, F3, FABP4, HSD17B2, IGF1R, INSR, KIT, MET, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCD, RORC, SMAD3, SRC, TEK, TRPV1, TYR |
7.60843 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, MIF, PTGES, TBXAS1 |
7.59253 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, APP, BCL2, CYP19A1, CYP1B1, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MIF, MMP9, SMAD3, SRC, TEK |
7.55651 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, EGFR, F3, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
7.54475 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, AKR1B10, ALOX15, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, ERBB2, FABP3, FABP4, FUT7, KIT, MET, MIF, PPARA, PTGES, TBXAS1 |
7.54183 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP9, PIM1, PRKCD, PTPN1, SMAD3, SRC, TEK |
7.54006 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD3, EGFR, ERBB2, F10, F3, INSR, KIT, MET, SRC, TEK, XDH |
7.41059 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, F10, F3, FABP4, FLT3, GPR35, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
7.3863 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
7.34301 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP2, MMP9, NUAK1, POLA1, POLB, PRKCD, PTPN1, RORC, SMAD3, SRC, TOP2A, TRPV1 |
7.24719 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, APP, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD3, EGFR, FLT3, PTGES, RORC, SRC, TEK, TRPV1, TYR |
7.2069 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
7.2069 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA2, CA7, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
7.07495 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, FABP3, FLT3, INSR, KIT, PPARA, PRKCD, SRC, TEK, TRPV1 |
7.01826 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MMP2, MMP9, PRKCD, RORC, SMAD3, SRC, TRPV1 |
7.01826 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, CHRM5, DRD3, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
6.98532 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, CHRM5, DRD3, DUSP3, EGFR, ERBB2, FABP3, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
6.91676 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, MIF, PPARA, PTGES, TBXAS1 |
6.91676 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
ALOX15, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, PTGES, TBXAS1 |
6.87863 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, POLB, PPARA, SMAD3, SRC, TEK, TYR |
6.75224 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, AKR1B10, APP, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2 |
6.73999 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CDC25B, CHRM1, CSNK2A1, DRD3, EGFR, ERBB2, F3, FLT3, IGF1R, INSR, KDR, KIT, MIF, MMP12, MMP2, MMP9, PIM1, TEK |
6.67939 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALOX15, ALPL, APEX1, APP, AXL, BCL2, CYP1A1, CYP1B1, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MMP2, PRKCD, RORC, SMAD3, SRC, TRPV1 |
6.55927 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F10, F3, INSR, KIT, MET, SRC, TEK |
6.55733 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APEX1, APP, AXL, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, FABP3, FABP4, FLT3, GPR35, INSR, MET, POLA1, POLB, SMAD3, SRC, TRPV1 |
6.37738 |
[BP] GO:0007197 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.37738 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD3, FABP3, PPARA, TRPV1 |
6.15411 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, HSPA1A, IGF1R, KDR, MIF, MMP9, PIM1, PRKCD, PTPN1, SMAD3, SRC, TEK |
6.14154 |
[BP] GO:0007207 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
5.92931 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CHRM5, CYP1A1, DRD3, FABP3, FLT3, HCAR2, KIT, PPARA, PRKCD, RORC, SRC, TEK |
5.92931 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, PTPN1, SRC, TEK, XDH |
5.90458 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP3, FLT3, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
5.88423 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FABP3, FLT3, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
5.88423 |
[BP] GO:0030335 |
positive regulation of cell migration
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK |
5.88423 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
5.84945 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, TYR, XDH |
5.84945 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, APP, AURKB, BCL2, CA2, CYP1A1, DRD3, EGFR, HSPA1A, KIT, MMP2, POLB, PPARA, SMAD3, SRC, TEK, TRPV1, TYR |
5.83329 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, ALOX15, APP, AXL, BCL2, CA2, CA7, CACNA1C, CHRM1, CYP19A1, DRD3, EGFR, ERBB2, GPR35, HCAR2, HSPA1A, INSR, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, SMAD3, SRC, TRPV1 |
5.78029 |
[BP] GO:0043408 |
regulation of MAPK cascade
|
ADORA1, ALOX15, APP, DUSP3, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MIF, PRKCD, PTPN1, SRC, TEK, XDH |
5.7246 |
[BP] GO:2000147 |
positive regulation of cell motility
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK |
5.7246 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALOX15, ALPL, APP, AXL, BCL2, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DUSP3, EGFR, ERBB2, FLT3, HSD11B1, HSD17B2, INSR, KDR, KIT, MMP9, PIM1, POLB, PPARA, RORC, SMAD3, SRC, TEK, TYR |
5.7 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.6425 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
5.6425 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, TYR, XDH |
5.6306 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK |
5.60052 |
[BP] GO:0006468 |
protein phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
5.60033 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALOX15, ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, PTPN1, SRC, TEK, XDH |
5.55328 |
[BP] GO:0032787 |
None
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PPARA, PTGES, TBXAS1 |
5.52048 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, EGFR, ERBB2, HSPA1A, KIT, MIF, MMP2, MMP9, NUAK1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, SMAD3, SRC, TEK, TOP2A, TRPV1 |
5.51276 |
[BP] GO:0040017 |
positive regulation of locomotion
|
APP, BCL2, EGFR, F10, F3, IGF1R, INSR, KDR, KIT, MET, MMP9, SMAD3, SRC, TEK |
5.4307 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, APP, AXL, BCL2, CA2, CHRM1, CYP19A1, DRD3, EGFR, ERBB2, HCAR2, INSR, MIF, MMP12, PRKCD, SMAD3, SRC, TRPV1 |
5.42608 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, PRKCD, SRC |
5.41537 |
[BP] GO:0043405 |
regulation of MAP kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, IGF1R, INSR, KIT, MIF, PRKCD, PTPN1, SRC |
5.37143 |
[BP] GO:1903725 |
regulation of phospholipid metabolic process
|
CHRM5, FABP3, FLT3, KIT, PRKCD, SRC, TEK |
5.34698 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.34337 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SRC, TEK |
5.33927 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, APP, AXL, BCL2, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CYP1B1, DRD3, EGFR, ERBB2, F3, GPR35, HCAR2, HSPA1A, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PRKCD, SMAD3, SRC, TEK, TRPV1, XDH |
5.31786 |
[BP] GO:1903727 |
positive regulation of phospholipid metabolic process
|
FABP3, FLT3, KIT, PRKCD, SRC, TEK |
5.30284 |
[BP] GO:0043410 |
positive regulation of MAPK cascade
|
ADORA1, ALOX15, APP, EGFR, ERBB2, FLT3, INSR, KDR, KIT, MIF, PTPN1, SRC, TEK, XDH |
5.22471 |
[BP] GO:0044057 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, DRD3, EGFR, GPR35, HCAR2, KIT, SMAD3, TRPV1 |
5.15114 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
5.10613 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, PRKCD, SRC |
5.00589 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CSNK2A1, CYP1A1, CYP1A2, EGFR, FABP3, FLT3, HSD17B2, PTGES, RORC, SRC, TYR |
4.99037 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, CYP1A1, CYP1A2, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, FUT7, GLO1, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A, TYR, XDH |
4.93122 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, ALOX15, BCL2, CYP1A1, EGFR, ERBB2, PPARA, SMAD3 |
4.90998 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD3, FABP3, PPARA, TRPV1 |
4.9085 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, APP, AXL, BCL2, CA2, CHRM3, CYP1B1, DRD3, EGFR, F3, HCAR2, HSPA1A, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, SMAD3, SRC, TEK, TRPV1 |
4.90283 |
[BP] GO:0001934 |
positive regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SRC, TEK, XDH |
4.86125 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KIT, MET, MIF, MMP9, NUAK1, PIM1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TRPV1, XDH |
4.76541 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, DRD3, EGFR, HCAR2, KDR, MIF, SRC, TRPV1 |
4.75318 |
[BP] GO:0010038 |
response to metal ion
|
ALOX15, APP, BCL2, CA2, CYP1A1, CYP1A2, EGFR, FABP4, KIT, MMP9, PTGES |
4.73776 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, APP, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PRKCD, SRC, TEK, TRPV1, TYR |
4.70214 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD3, KDR, POLB, PRKCD, SRC |
4.66107 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
4.64554 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, APP, AXL, BCL2, CA1, CA2, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP1B1, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TRPV1 |
4.62893 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KIT, MIF, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
4.62386 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, EGFR, ERBB2, F10, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK, TOP2A |
4.62174 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP2, MMP9, PTPN1, SMAD3, SRC, TEK |
4.62125 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SRC, TEK, XDH |
4.61335 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ERBB2, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
4.5799 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, FABP3, FABP4, GLO1, GPR35, HCAR2, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
4.50917 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, APP, AXL, BCL2, CYP1B1, EGFR, HSPA1A, MMP9, PRKCD, SRC |
4.46601 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, TYR, XDH |
4.46466 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MIF, MMP9, PPARA, PRKCD, PTPN1, SRC, TEK, XDH |
4.46466 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SRC, TEK, XDH |
4.45053 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD3, KDR, SRC, TRPV1 |
4.43169 |
[BP] GO:0070372 |
regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, DUSP3, EGFR, ERBB2, KDR, MIF, PTPN1, SRC, TEK |
4.42865 |
[BP] GO:1901652 |
response to peptide
|
AKR1B1, APEX1, APP, FABP3, IGF1R, INSR, PPARA, PRKCD, SRC, TEK, TRPV1 |
4.41012 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.38983 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, APP, CA2, CACNA1C, CHRM1, DRD3, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTPN1, SMAD3, SRC |
4.38061 |
[BP] GO:0016310 |
phosphorylation
|
APP, AURKB, AXL, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.36647 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, FABP3, FABP4, GLO1, GPR35, HSPA1A, IGF1R, KDR, KIT, MET, MIF, MMP12, MMP9, PIM1, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
4.32739 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, APP, DRD3, EGFR, FABP3, FLT3, IGF1R, INSR, MMP2, PPARA, PRKCD, SRC, TEK, TRPV1, TYR |
4.32712 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD3, EGFR, KIT, PPARA, RORC, SRC, TOP2A |
4.30919 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, PRKCD, SRC |
4.27867 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
4.25877 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP4, FLT3, GPR35, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP2, MMP9, NUAK1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
4.2305 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA9, CYP1A1, CYP1B1, DRD3, EGFR, FABP3, KDR, POLB, PRKCD, SRC, TRPV1 |
4.20201 |
[BP] GO:0045787 |
positive regulation of cell cycle
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, INSR, MIF, SRC |
4.17794 |
[BP] GO:0007213 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
4.16115 |
[BP] GO:0043549 |
regulation of kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KIT, MIF, PRKCD, PTPN1, SRC, TEK |
4.15372 |
[BP] GO:0001503 |
ossification
|
ALOX15, ALPL, BCL2, EGFR, MMP2, MMP9, TEK |
4.13618 |
[BP] GO:0050730 |
None
|
ADORA1, APP, EGFR, FLT3, KIT, MIF, PRKCD, PTPN1, SRC |
4.10253 |
[BP] GO:2000377 |
regulation of reactive oxygen species metabolic process
|
BCL2, CYP1B1, EGFR, INSR, PRKCD, SMAD3, TRPV1, XDH |
4.10228 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
4.10103 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, APP, CYP19A1, DUSP3, EGFR, F3, FABP4, HSPA1A, IGF1R, MET, MIF, MMP12, MMP2, NUAK1, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
4.09655 |
[BP] GO:0007166 |
cell surface receptor signaling pathway
|
ADORA1, ADORA3, APP, AXL, BCL2, CA1, CSNK2A1, EGFR, ERBB2, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, MIF, MMP2, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, TRPV1 |
4.09381 |
[BP] GO:0007346 |
regulation of mitotic cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, PIM1, SMAD3, TOP2A |
4.04405 |
[BP] GO:0051247 |
positive regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, EGFR, ERBB2, F3, FLT3, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
3.99544 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, ALOX15, BCL2, CYP19A1, DRD3, DUSP3, EGFR, ERBB2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
3.99321 |
[BP] GO:0007193 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, CHRM5, DRD3 |
3.98378 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ERBB2, F3, FABP3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.96763 |
[BP] GO:0031399 |
regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, PTPN1, SRC, TEK, XDH |
3.95239 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
FABP3, FLT3, KIT, PPARA, PRKCD, SRC, TEK |
3.95239 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, APP, EGFR, ERBB2, FLT3, IGF1R, INSR, KIT, MMP2, PRKCD, SMAD3, SRC, TRPV1 |
3.88083 |
[BP] GO:0045859 |
regulation of protein kinase activity
|
ADORA1, APP, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KIT, MIF, PRKCD, PTPN1, SRC |
3.87087 |
[BP] GO:0051338 |
regulation of transferase activity
|
ADORA1, APP, AURKB, CDC25B, DUSP3, EGFR, ERBB2, FABP4, FLT3, IGF1R, INSR, KIT, MIF, PRKCD, PTPN1, SRC, TEK |
3.86495 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD11B1, HSD17B1, HSD17B2 |
3.84462 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD3, EGFR, ERBB2, IGF1R, INSR, KDR, KIT, MET, MIF, NUAK1, POLB, PRKCD, PTPN1, SRC, TEK |
3.82913 |
[BP] GO:0032270 |
positive regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, F3, FLT3, HSPA1A, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
3.81303 |
[BP] GO:0071900 |
regulation of protein serine/threonine kinase activity
|
ADORA1, DUSP3, EGFR, ERBB2, FLT3, IGF1R, INSR, KIT, MIF, PRKCD, PTPN1, SRC |
3.77926 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, AKR1B10, ALOX15, APP, BCL2, CYP19A1, CYP1A1, CYP1B1, DRD3, MAOA, TYR |
3.77866 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, DRD3, DUSP3, EGFR, ERBB2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, XDH |
3.75202 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, INSR, KDR, SRC |
3.73759 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, DRD3, DUSP3, EGFR, ERBB2, GPR35, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, XDH |
3.73759 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CYP19A1, CYP1A1, CYP1B1, EGFR, HCAR2, HSD11B1, HSD17B1, HSD17B2 |
3.73759 |
[BP] GO:0043085 |
positive regulation of catalytic activity
|
ADORA1, ADRB1, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, F3, FLT3, HSPA1A, INSR, KIT, MIF, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
3.72254 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, APP, AURKB, CSNK2A1, CYP1B1, CYP2D6, DRD3, DUSP3, FABP4, GPR35, IGF1R, MET, MMP9, PIM1, PPARA, PRKCD, PTPN1, SRC |
3.71944 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, DRD3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PRKCD, SMAD3, SRC, TEK |
3.69518 |
[BP] GO:1904951 |
positive regulation of establishment of protein localization
|
ACHE, APP, BCL2, CHRM1, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, SMAD3, SRC |
3.69468 |
[BP] GO:0043406 |
positive regulation of MAP kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, INSR, KIT, MIF, PTPN1, SRC |
3.69468 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD3, DUSP3, HSPA1A, IGF1R, MET, MIF, MMP9, PRKCD, PTPN1, SRC, XDH |
3.68062 |
[BP] GO:0070201 |
None
|
ACHE, APP, BCL2, CACNA1C, CHRM1, DRD3, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTPN1, SMAD3, SRC |
3.67817 |
[BP] GO:0051098 |
regulation of binding
|
APP, AURKB, BCL2, CYP2D6, MET, MMP9, PPARA, PRKCD, SMAD3, SRC |
3.67257 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, FABP3, FABP4, GPR35, INSR, MET, SMAD3, TRPV1 |
3.63646 |
[BP] GO:0043436 |
oxoacid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
3.61481 |
[BP] GO:2000379 |
positive regulation of reactive oxygen species metabolic process
|
EGFR, INSR, PRKCD, SMAD3, TRPV1, XDH |
3.614 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, DRD3, EGFR, HSPA1A, MAOA |
3.59819 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, APP, CYP1A1, CYP1B1, EGFR, FLT3, RORC, SRC, TRPV1 |
3.59308 |
[BP] GO:0095500 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.58925 |
[BP] GO:1903831 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.58925 |
[BP] GO:0043393 |
regulation of protein binding
|
APP, AURKB, BCL2, MET, MMP9, PPARA, PRKCD, SRC |
3.565 |
[BP] GO:0001775 |
cell activation
|
ALOX5, APP, AXL, BCL2, EGFR, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PRKCD, RORC, SMAD3, SRC, TRPV1 |
3.56415 |
[BP] GO:0045931 |
positive regulation of mitotic cell cycle
|
APEX1, APP, CDC25B, CYP1A1, DRD3, DUSP3, INSR |
3.55974 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, APP, AURKB, BCL2, CDC25B, EGFR, ERBB2, F3, FLT3, HSPA1A, INSR, KIT, MET, MIF, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
3.54489 |
[BP] GO:0031401 |
positive regulation of protein modification process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, EGFR, ERBB2, FLT3, INSR, KDR, KIT, MIF, MMP9, PRKCD, PTPN1, SRC, TEK, XDH |
3.54037 |
[BP] GO:0006082 |
organic acid metabolic process
|
ALOX15, ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, FABP3, GLO1, MIF, PIM1, PPARA, PTGES, TBXAS1, TYR |
3.53897 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.5268 |
[BP] GO:2001243 |
negative regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTPN1, SRC |
3.50161 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, KDR, PRKCD, SRC, TRPV1 |
3.49906 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, APP, AXL, CYP1B1, EGFR, IGF1R, INSR, MMP2, MMP9, PRKCD, RORC, SRC, TRPV1 |
3.46099 |
[BP] GO:0033674 |
positive regulation of kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FLT3, INSR, KIT, MIF, PRKCD, PTPN1, SRC, TEK |
3.46099 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, POLB, PPARA, SMAD3, SRC, TEK |
3.39728 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, SRC, TEK |
3.37388 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD3 |
3.35724 |
[BP] GO:0007271 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.33336 |
[BP] GO:0051701 |
interaction with host
|
AXL, EGFR, HSPA1A, INSR, MET, SMAD3, SRC |
3.32433 |
[BP] GO:0033554 |
cellular response to stress
|
AKR1B1, ALOX15, APEX1, AXL, BCL2, CA2, CA9, CYP1B1, EGFR, HSPA1A, MIF, MMP9, NUAK1, POLA1, POLB, PRKCD, PTPN1, SRC, TOP2A, TRPV1 |
3.31905 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD3, EGFR, HCAR2, MIF, MMP12, SRC, TRPV1 |
3.31231 |
[BP] GO:0051223 |
None
|
ACHE, APP, CACNA1C, CHRM1, DRD3, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTPN1, SMAD3, SRC |
3.29305 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, ALOX15, APP, AURKB, BCL2, CDC25B, CSNK2A1, DRD3, EGFR, ERBB2, F3, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, XDH |
3.29117 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD3, EGFR, F3, FABP4, KDR, MET, MIF, MMP12, PPARA, PRKCD, SMAD3, TEK |
3.29024 |
[BP] GO:0044236 |
multicellular organism metabolic process
|
ADRB1, MMP1, MMP12, MMP2, MMP9, TRPV1 |
3.25641 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1, PRKCD |
3.25641 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
3.25641 |
[BP] GO:0051222 |
positive regulation of protein transport
|
ACHE, APP, CHRM1, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, SMAD3, SRC |
3.24836 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AKR1B10, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP2D6, FABP3, FABP4, FUT7, HSPA1A, MAOA, MMP1, MMP12, MMP2, MMP9, SRC, XDH |
3.2408 |
[BP] GO:0006721 |
terpenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
3.2408 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, APP, BCL2, CACNA1C, CHRM1, CSNK2A1, DRD3, EGFR, ERBB2, HCAR2, MIF, MMP12, PRKCD, PTPN1, SMAD3, SRC |
3.23844 |
[BP] GO:0051347 |
positive regulation of transferase activity
|
ADORA1, AURKB, CDC25B, EGFR, ERBB2, FLT3, INSR, KIT, MIF, PRKCD, PTPN1, SRC, TEK |
3.23844 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, HSD17B1, HSD17B2 |
3.22593 |
[BP] GO:0071417 |
cellular response to organonitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PRKCD, SRC, TRPV1 |
3.21229 |
[BP] GO:0048534 |
hematopoietic or lymphoid organ development
|
BCL2, FLT3, KDR, KIT, POLB, TEK, TYR |
3.19888 |
[BP] GO:0043552 |
positive regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
3.18185 |
[BP] GO:0051726 |
regulation of cell cycle
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD3, DUSP3, EGFR, HSPA1A, INSR, MIF, PIM1, SMAD3, SRC, TOP2A |
3.18092 |
[BP] GO:0046903 |
None
|
ALOX5, APP, AXL, CA2, CA9, CHRM1, CHRM3, CHRM5, DRD3, HSPA1A, KIT, MIF, MMP9, PRKCD, TRPV1, XDH |
3.17527 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
3.17426 |
[BP] GO:0006940 |
None
|
ADORA1, CHRM1, CHRM2, CHRM3, KIT |
3.1498 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CYP19A1, MMP12, PPARA, PRKCD, SMAD3, TEK |
3.14465 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.14159 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, RORC |
3.11192 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CYP19A1, PPARA, PRKCD, SMAD3, TEK |
3.09173 |
[BP] GO:0071363 |
cellular response to growth factor stimulus
|
APP, EGFR, ERBB2, INSR, KDR, SMAD3, SRC, TRPV1 |
3.08338 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, APP, BCL2, CA2, CA7, CACNA1C, CHRM1, DRD3, GPR35, MIF, MMP9, PRKCD |
3.06526 |
[BP] GO:0019538 |
protein metabolic process
|
ACHE, ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ERBB2, F10, F3, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLB, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
3.03913 |
[BP] GO:0090218 |
positive regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
3.03445 |
[BP] GO:0010638 |
positive regulation of organelle organization
|
ALOX15, AURKB, BCL2, DRD3, HSPA1A, INSR, KDR, MET, MMP9, SMAD3, SRC, TEK |
3.02346 |
[BP] GO:0045860 |
positive regulation of protein kinase activity
|
ADORA1, CDC25B, EGFR, ERBB2, FLT3, INSR, KIT, MIF, PRKCD, PTPN1, SRC |
3.02346 |
[BP] GO:0002320 |
lymphoid progenitor cell differentiation
|
BCL2, FLT3, KIT |
3.02346 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR, PRKCD |
3.00296 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, CHRM1, CHRM2, CHRM3, CHRM5, DRD3 |
2.9763 |
[BP] GO:0001505 |
regulation of neurotransmitter levels
|
ACHE, CYP1B1, DRD3, EGFR, INSR, MAOA, SMAD3, TRPV1 |
2.97604 |
[BP] GO:1901699 |
cellular response to nitrogen compound
|
AKR1B1, APEX1, APP, EGFR, IGF1R, INSR, MMP2, PRKCD, SRC, TRPV1 |
2.95083 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.94339 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.93175 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
AKR1B10, CYP1A1, CYP1A2, CYP1B1, CYP2D6, EGFR |
2.91132 |
[BP] GO:0002521 |
leukocyte differentiation
|
AXL, BCL2, FLT3, FUT7, GLO1, KIT, MMP9, RORC |
2.91132 |
[BP] GO:0031323 |
regulation of cellular metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.88021 |
[BP] GO:0006286 |
base-excision repair, base-free sugar-phosphate removal
|
APEX1, POLB |
2.87225 |
[BP] GO:0065007 |
biological regulation
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA12, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.86393 |
[BP] GO:0046456 |
icosanoid biosynthetic process
|
ALOX15, ALOX5, MIF, PTGES |
2.86385 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, MMP2, PPARA, SMAD3, SRC, TEK |
2.85431 |
[BP] GO:0071902 |
positive regulation of protein serine/threonine kinase activity
|
ADORA1, EGFR, ERBB2, FLT3, INSR, KIT, MIF, PTPN1, SRC |
2.8489 |
[BP] GO:0042060 |
None
|
ALOX15, EGFR, ERBB2, PPARA, SMAD3 |
2.84167 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, ALOX15, APP, AXL, BCL2, CA2, CYP19A1, DUSP3, ERBB2, HCAR2, HSPA1A, KIT, MIF, MMP12, MMP2, PRKCD, PTPN1, SMAD3, SRC |
2.83578 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.82404 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD3, MAOA, TYR |
2.82144 |
[BP] GO:0070374 |
positive regulation of ERK1 and ERK2 cascade
|
ALOX15, APP, EGFR, KDR, MIF, SRC, TEK |
2.80602 |
[BP] GO:0008610 |
lipid biosynthetic process
|
ACHE, AKR1B1, ALOX15, CSNK2A1, CYP19A1, CYP1A1, HSD11B1, HSD17B1, HSD17B2, MIF, PTGES |
2.77635 |
[BP] GO:0043434 |
None
|
APEX1, FABP3, INSR, PPARA, PRKCD, SRC, TEK, TRPV1 |
2.7457 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CYP19A1, DRD3, MIF, PPARA, PRKCD, SMAD3, TEK |
2.73871 |
[BP] GO:0070848 |
response to growth factor
|
APP, EGFR, ERBB2, INSR, KDR, SMAD3, SRC, TRPV1 |
2.73871 |
[BP] GO:0044070 |
regulation of anion transport
|
ADORA1, CA2, CA7, MIF, PRKCD |
2.72832 |
[BP] GO:0050801 |
ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, FABP3, GPR35, SMAD3, TRPV1 |
2.72071 |
[BP] GO:0030155 |
regulation of cell adhesion
|
ALOX15, BCL2, CYP1B1, DUSP3, ERBB2, KDR, NUAK1, PPARA, PRKCD, SMAD3, SRC, TEK |
2.72071 |
[BP] GO:1904407 |
positive regulation of nitric oxide metabolic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.71607 |
[BP] GO:0045429 |
positive regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.71607 |
[BP] GO:0003013 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR, SRC, TEK |
2.71295 |
[BP] GO:0006464 |
cellular protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ERBB2, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.70692 |
[BP] GO:0036211 |
protein modification process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ERBB2, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.70692 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CYP19A1, EGFR, FABP4, HSPA1A, MMP12, MMP2, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK |
2.69898 |
[BP] GO:1903522 |
None
|
ADORA1, ADORA3, ADRB1, CACNA1C, CHRM1, CHRM2, CHRM3, EGFR |
2.68905 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, DRD3, PPARA |
2.68336 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, APP, AXL, BCL2, CDC25B, CYP1A1, EGFR, ERBB2, FABP4, FLT3, FUT7, GLO1, KDR, KIT, MET, MIF, MMP2, MMP9, PRKCD, RORC, SMAD3, SRC, TEK, TOP2A |
2.68324 |
[BP] GO:1901653 |
cellular response to peptide
|
AKR1B1, APEX1, APP, IGF1R, INSR, PRKCD, SRC |
2.68324 |
[BP] GO:0009894 |
regulation of catabolic process
|
ADORA1, APEX1, BCL2, CSNK2A1, EGFR, HCAR2, HSPA1A, INSR, KDR, MET, PPARA, PRKCD, PTPN1, SMAD3 |
2.66113 |
[BP] GO:0044267 |
cellular protein metabolic process
|
ALPL, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ERBB2, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP2, NUAK1, PIM1, POLB, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.65229 |
[BP] GO:0043551 |
regulation of phosphatidylinositol 3-kinase activity
|
FLT3, KIT, SRC, TEK |
2.65022 |
[BP] GO:0009968 |
negative regulation of signal transduction
|
BCL2, DRD3, DUSP3, EGFR, ERBB2, HSPA1A, IGF1R, MET, MIF, MMP12, MMP9, PRKCD, PTPN1, SMAD3, SRC, XDH |
2.59497 |
[BP] GO:0032075 |
None
|
HSPA1A, PRKCD, PTPN1 |
2.57534 |
[BP] GO:0032268 |
regulation of cellular protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
2.5742 |
[BP] GO:0071248 |
cellular response to metal ion
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.56426 |
[BP] GO:0048731 |
system development
|
ACHE, ADORA1, ALPL, CACNA1C, CHRM1, CHRM2, CHRM3, ERBB2, MMP9, SMAD3, SRC, TEK |
2.54041 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, APP, CA2, CA7, DRD3, EGFR, KIT |
2.54041 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, APP, CA2, CA7, DRD3, EGFR, KIT |
2.54041 |
[BP] GO:0008631 |
intrinsic apoptotic signaling pathway in response to oxidative stress
|
BCL2, CYP1B1, PRKCD |
2.5013 |
[BP] GO:0050878 |
regulation of body fluid levels
|
ADORA1, AKR1B1, CHRM1, CHRM3, F10, F3, MET, PRKCD, XDH |
2.46664 |
[BP] GO:0098502 |
DNA dephosphorylation
|
APEX1, POLB |
2.46664 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.46664 |
[BP] GO:0002520 |
None
|
CACNA1C, SMAD3 |
2.46664 |
[BP] GO:0016477 |
cell migration
|
AXL, CYP1B1, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.46444 |
[BP] GO:0010564 |
regulation of cell cycle process
|
APEX1, APP, AURKB, BCL2, CDC25B, CSNK2A1, CYP1A1, DRD3, EGFR, HSPA1A, INSR, MIF |
2.45906 |
[BP] GO:0090257 |
None
|
ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, KIT, SMAD3 |
2.45804 |
[BP] GO:0043065 |
positive regulation of apoptotic process
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PRKCD, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.45699 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, ALOX15, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, KIT, MET |
2.44328 |
[BP] GO:0045321 |
leukocyte activation
|
ALOX5, AXL, BCL2, FLT3, FUT7, HSPA1A, KIT, MIF, MMP9, PRKCD, RORC, SMAD3, TRPV1 |
2.44019 |
[BP] GO:0043412 |
macromolecule modification
|
ALPL, APEX1, APP, AURKB, AXL, BCL2, CDC25B, CHRM1, CHRM3, CSNK2A1, DUSP3, EGFR, ERBB2, F10, FLT3, FUT7, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLB, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.43715 |
[BP] GO:2001242 |
regulation of intrinsic apoptotic signaling pathway
|
BCL2, HSPA1A, MIF, MMP9, PTPN1, SRC |
2.43078 |
[BP] GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling
|
EGFR, FLT3, KDR, KIT, TEK |
2.43078 |
[BP] GO:0007568 |
aging
|
APEX1, AURKB, BCL2, CYP1A1, MIF, POLB, PRKCD |
2.43078 |
[BP] GO:0043068 |
positive regulation of programmed cell death
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PRKCD, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.42722 |
[BP] GO:0042752 |
None
|
ADORA1, DRD3, PPARA, RORC, TOP2A |
2.41191 |
[BP] GO:1901184 |
None
|
ADORA1, APP, EGFR, ERBB2, MMP9 |
2.39206 |
[BP] GO:0006937 |
None
|
ADORA1, CACNA1C, CHRM1, CHRM2, CHRM3, KIT |
2.39138 |
[BP] GO:0046649 |
lymphocyte activation
|
AXL, BCL2, FLT3, FUT7, KIT, PRKCD, RORC, SMAD3 |
2.38083 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.3771 |
[BP] GO:0051704 |
multi-organism process
|
APP, AXL, BCL2, CHRM2, CYP1A1, DRD3, EGFR, HSPA1A, INSR, KDR, MET, MMP1, MMP12, POLA1, PRKCD, SMAD3, SRC |
2.36976 |
[BP] GO:0003008 |
None
|
ADORA1, ADRB1, AKR1B1, APP, BCL2, CHRM1, CHRM3, CHRM5, CYP1B1, DRD3, EGFR, INSR, KIT, SRC, TEK, TRPV1, TYR |
2.3673 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, PTGES, SRC |
2.3673 |
[BP] GO:1903428 |
positive regulation of reactive oxygen species biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.3673 |
[BP] GO:0050994 |
None
|
ADORA1, HCAR2, PPARA, PRKCD |
2.3673 |
[BP] GO:0043550 |
regulation of lipid kinase activity
|
FLT3, KIT, SRC, TEK |
2.3673 |
[BP] GO:0051828 |
entry into other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.36593 |
[BP] GO:0051806 |
entry into cell of other organism involved in symbiotic interaction
|
AXL, EGFR, HSPA1A, MET, SRC |
2.36593 |
[BP] GO:0030260 |
entry into host cell
|
AXL, EGFR, HSPA1A, MET, SRC |
2.36593 |
[BP] GO:0044409 |
entry into host
|
AXL, EGFR, HSPA1A, MET, SRC |
2.36593 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, APP, AURKB, BCL2, CSNK2A1, CYP2D6, DRD3, DUSP3, EGFR, FABP4, HCAR2, HSPA1A, IGF1R, KDR, MET, MIF, MMP12, MMP9, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TRPV1, XDH |
2.35928 |
[BP] GO:0051234 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM3, CHRM5, DRD3, EGFR, F10, FABP3, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, PRKCD, SRC, TRPV1, XDH |
2.34965 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.34901 |
[BP] GO:0001952 |
regulation of cell-matrix adhesion
|
BCL2, KDR, SMAD3, SRC, TEK |
2.33 |
[BP] GO:0048732 |
gland development
|
BCL2, CSNK2A1, CYP19A1, EGFR, INSR, SMAD3, TYR |
2.32955 |
[BP] GO:0009605 |
response to external stimulus
|
ADORA1, ALPL, AXL, BCL2, CHRM2, CYP1A1, CYP1A2, DRD3, EGFR, KIT, MMP12, PRKCD, PTGES, SMAD3, SRC, TRPV1, TYR |
2.32955 |
[BP] GO:0050794 |
regulation of cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX15, APEX1, APP, AURKB, AXL, BCL2, CA1, CA2, CA7, CA9, CACNA1C, CDC25B, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, GLO1, GPR35, HCAR2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.32437 |
[BP] GO:0051893 |
regulation of focal adhesion assembly
|
KDR, SMAD3, SRC, TEK |
2.31868 |
[BP] GO:0090109 |
regulation of cell-substrate junction assembly
|
KDR, SMAD3, SRC, TEK |
2.31868 |
[BP] GO:0050678 |
None
|
EGFR, ERBB2, F3, KDR, MMP12, SMAD3, TEK, XDH |
2.31318 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
APP, BCL2, CA12, CA2, CA7, CACNA1C, DRD3, EGFR, GPR35, SMAD3, TRPV1 |
2.27995 |
[BP] GO:0071241 |
cellular response to inorganic substance
|
ALOX15, CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.26164 |
[BP] GO:0046686 |
response to cadmium ion
|
CYP1A2, EGFR, KIT, MMP9 |
2.26101 |
[BP] GO:0050731 |
positive regulation of peptidyl-tyrosine phosphorylation
|
ADORA1, FLT3, KIT, MIF, PTPN1, SRC |
2.25002 |
[BP] GO:0080135 |
regulation of cellular response to stress
|
APP, DUSP3, EGFR, HSPA1A, IGF1R, MET, MIF, NUAK1, PRKCD, PTPN1, XDH |
2.24281 |
[BP] GO:0006954 |
inflammatory response
|
ADORA1, ADORA3, ALOX15, AXL, KIT, MIF, POLB, PTGES, TRPV1 |
2.24233 |
[BP] GO:1903391 |
regulation of adherens junction organization
|
KDR, SMAD3, SRC, TEK |
2.23636 |
[BP] GO:0045428 |
regulation of nitric oxide biosynthetic process
|
EGFR, INSR, SMAD3, TRPV1 |
2.23636 |
[BP] GO:0050679 |
None
|
EGFR, ERBB2, F3, KDR, MMP12, TEK |
2.2292 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, APP, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, HSPA1A, INSR, PIM1, SMAD3 |
2.2273 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.2273 |
[BP] GO:0051128 |
regulation of cellular component organization
|
ALOX15, APP, AURKB, AXL, BCL2, CSNK2A1, DRD3, EGFR, ERBB2, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP9, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
2.22069 |
[BP] GO:0022612 |
gland morphogenesis
|
BCL2, EGFR, POLB |
2.22069 |
[BP] GO:0040011 |
locomotion
|
AXL, CYP1B1, EGFR, FUT7, KDR, KIT, MET, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.2161 |
[BP] GO:0002793 |
None
|
ACHE, ADORA1, EGFR, HCAR2, MIF, MMP12, SRC |
2.21242 |
[BP] GO:0006810 |
None
|
ACHE, ADORA1, ALOX15, ALOX5, APP, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM1, CHRM3, CHRM5, DRD3, F10, FABP3, HSPA1A, KIT, MIF, MMP12, MMP9, PPARA, PRKCD, SRC, TRPV1, XDH |
2.2021 |
[BP] GO:0051171 |
regulation of nitrogen compound metabolic process
|
ADORA1, ADORA3, ADRB1, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CSNK2A1, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F3, FABP3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.19809 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM5, DRD3, FABP3, PPARA, TRPV1 |
2.19173 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP2D6 |
2.19173 |
[BP] GO:0010942 |
positive regulation of cell death
|
BCL2, CYP1B1, F3, HCAR2, MMP9, PRKCD, SMAD3, SRC, TOP2A, TRPV1, XDH |
2.19124 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.1699 |
[BP] GO:0060255 |
regulation of macromolecule metabolic process
|
ACHE, ADORA1, ADORA3, ALOX15, APEX1, APP, AURKB, BCL2, CA9, CDC25B, CHRM5, CSNK2A1, CYP1A2, CYP1B1, DRD3, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, GLO1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MIF, MMP12, MMP9, NUAK1, PIM1, POLA1, PPARA, PRKCD, PTPN1, RORC, SMAD3, SRC, TEK, TOP2A, TRPV1, XDH |
2.16008 |
[BP] GO:0042737 |
drug catabolic process
|
ACHE, CYP1A2, CYP2A6, CYP2D6, MAOA |
2.15765 |
[BP] GO:0050920 |
regulation of chemotaxis
|
CYP19A1, F3, KDR, MET, MIF, SMAD3 |
2.15515 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, AKR1B10, CSNK2A1, DRD3, MAOA |
2.15515 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, EGFR, HCAR2, MET, PPARA, SMAD3 |
2.14245 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, DRD3, EGFR, HCAR2, MIF, MMP12, SRC |
2.14245 |
[BP] GO:0048870 |
cell motility
|
AXL, CYP1B1, EGFR, FUT7, KDR, KIT, MIF, MMP1, MMP12, MMP9, PRKCD, SRC, TEK |
2.12952 |
[BP] GO:0007423 |
None
|
BCL2, CACNA1C, CYP1A1, EGFR, KIT |
2.12942 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF |
2.12886 |
[BP] GO:0051894 |
None
|
KDR, SMAD3, TEK |
2.12886 |
[BP] GO:0061900 |
None
|
APP, EGFR, TRPV1 |
2.12886 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.12886 |
[BP] GO:0051336 |
regulation of hydrolase activity
|
ADRB1, APP, CSNK2A1, EGFR, ERBB2, F3, HSPA1A, KIT, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, XDH |
2.11179 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, MET, TRPV1 |
2.10276 |
[BP] GO:0010810 |
regulation of cell-substrate adhesion
|
ALOX15, BCL2, KDR, SMAD3, SRC, TEK |
2.09577 |
[BP] GO:0030098 |
lymphocyte differentiation
|
AXL, BCL2, FLT3, FUT7, KIT, RORC |
2.09577 |
[BP] GO:0048608 |
reproductive structure development
|
AXL, BCL2, CYP19A1, HSD17B2, INSR, KIT, SRC |
2.09113 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, AKR1B10, CYP19A1, CYP1A2, CYP1B1, FABP3, FABP4 |
2.09113 |
[BP] GO:0050927 |
None
|
F3, KDR, SMAD3 |
2.08578 |
[BP] GO:0051246 |
regulation of protein metabolic process
|
ADORA1, ALOX15, APP, BCL2, CDC25B, CSNK2A1, DUSP3, EGFR, ERBB2, F3, FABP4, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MIF, MMP9, NUAK1, PRKCD, PTPN1, SMAD3, SRC, TEK, XDH |
2.07492 |
[BP] GO:0050890 |
None
|
ADORA1, APP, CHRM1, DRD3, EGFR, INSR, KIT |
2.07441 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, APP, CA2, CA7, EGFR |
2.06269 |
[BP] GO:0030574 |
collagen catabolic process
|
MMP1, MMP12, MMP2, MMP9 |
2.06152 |
[BP] GO:0022600 |
None
|
CHRM1, CHRM3, CHRM5, DRD3 |
2.06152 |
[BP] GO:0090068 |
positive regulation of cell cycle process
|
APEX1, APP, AURKB, CDC25B, CYP1A1, DRD3, INSR |
2.0598 |
[BP] GO:0046541 |
None
|
CHRM1, CHRM3 |
2.05685 |
[BP] GO:0098501 |
polynucleotide dephosphorylation
|
APEX1, POLB |
2.05685 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.05685 |
[BP] GO:0007598 |
None
|
F10, F3 |
2.05685 |
[BP] GO:0002318 |
myeloid progenitor cell differentiation
|
FLT3, KIT |
2.05685 |
[BP] GO:0050926 |
None
|
F3, KDR, SMAD3 |
2.04954 |
[BP] GO:1903393 |
None
|
KDR, SMAD3, TEK |
2.04954 |
[BP] GO:0014068 |
positive regulation of phosphatidylinositol 3-kinase signaling
|
FLT3, KDR, KIT, TEK |
2.0484 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, APP, AXL, BCL2, CDC25B, CYP19A1, CYP1A1, EGFR, HSD17B2, INSR, KIT, MMP2, MMP9, SRC, TOP2A |
2.03671 |
[BP] GO:0097746 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR |
2.03043 |
[BP] GO:0035296 |
None
|
ADORA1, ADRB1, CHRM1, CHRM3, EGFR |
2.03043 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, APP, AURKB, DRD3, EGFR, ERBB2, FABP3, IGF1R, INSR, KDR, MET, MMP12, PPARA, PRKCD, RORC, SMAD3, SRC, TOP2A, TRPV1 |
2.02804 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, APP, BCL2, DRD3 |
2.02804 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
EGFR, F3, FABP4, KDR, MET, MIF, SMAD3 |
2.02804 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, APP, AXL, BCL2, CA2, CYP1B1, DRD3, EGFR, ERBB2, F3, INSR, KDR, KIT, MIF, NUAK1, PIM1, PPARA, RORC, SMAD3, SRC, TEK, TRPV1, XDH |
2.02599 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, MIF |
2.02136 |
[BP] GO:0010634 |
positive regulation of epithelial cell migration
|
KDR, MET, MMP9, SRC, TEK |
2.02076 |
[BP] GO:0008285 |
negative regulation of cell proliferation
|
ADORA1, ADORA3, APP, BCL2, CYP1B1, ERBB2, FABP3, HSPA1A, PTGES, SMAD3, XDH |
2.01484 |
[BP] GO:0032069 |
None
|
HSPA1A, PRKCD, PTPN1 |
2.01484 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, HSD11B1, HSD17B1, HSD17B2 |
2.00928 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, MET, SMAD3, SRC |
2.00899 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, APP, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, DRD3, EGFR, ERBB2, F10, F3, FLT3, GLO1, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, MMP2, PIM1, PRKCD, PTPN1, SMAD3, SRC, TEK, TRPV1 |
4.76216 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALOX5, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, EGFR, ERBB2, F10, F3, FLT3, FUT7, GLO1, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, KIT, MAOA, MET, MMP2, PIM1, PRKCD, PTGES, PTPN1, SMAD3, SRC, TBXAS1, TEK, TRPV1, TYR |
4.50939 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRB1, ALOX15, APP, AXL, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, KIT, MET, SRC, TEK, TRPV1 |
4.41471 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX15, ALPL, APP, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CHRM1, CHRM2, CHRM3, CHRM5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, F3, FLT3, FUT7, GPR35, HCAR2, HSD11B1, HSD17B2, IGF1R, INSR, KDR, KIT, MAOA, MET, PTGES, PTPN1, SRC, TBXAS1, TEK, TRPV1, TYR |
4.10894 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, CA4, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, F10, F3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
4.0771 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, CHRM3, EGFR, ERBB2, TEK |
3.82921 |
[CC] GO:0005641 |
nuclear envelope lumen
|
ALOX5, APP, PTGES |
3.41166 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, APP, AURKB, BCL2, CA1, CA2, CA4, CA5A, CA5B, CA7, CACNA1C, CDC25B, CHRM2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, DUSP3, EGFR, ERBB2, F10, FABP3, FABP4, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, INSR, KDR, KIT, MAOA, MIF, MMP2, MMP9, PIM1, POLA1, PRKCD, PTGES, PTPN1, SMAD3, SRC, TBXAS1, TOP2A, TRPV1, TYR, XDH |
3.22228 |
[CC] GO:0098590 |
plasma membrane region
|
ADORA1, CA2, CA4, CA9, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, ERBB2, INSR, MET, SRC, TEK, TRPV1 |
2.91132 |
[CC] GO:0048471 |
perinuclear region of cytoplasm
|
ACHE, AKR1B1, APEX1, APP, CA4, EGFR, ERBB2, HSPA1A, PRKCD, PTGES, SRC, TYR |
2.84609 |
[CC] GO:0005887 |
integral component of plasma membrane
|
ADORA1, ADORA3, ADRB1, APP, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, FLT3, GPR35, IGF1R, INSR, KDR, MET, TEK, TRPV1 |
2.77635 |
[CC] GO:0044432 |
endoplasmic reticulum part
|
APP, BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, F10, FLT3, HSD11B1, HSD17B2, PTGES, PTPN1, TBXAS1 |
2.70445 |
[CC] GO:0031233 |
None
|
CA4, F10, F3 |
2.32758 |
[CC] GO:0045202 |
None
|
ACHE, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR |
2.16761 |
[CC] GO:0005789 |
endoplasmic reticulum membrane
|
BCL2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, EGFR, HSD11B1, HSD17B2, PTGES, TBXAS1 |
2.12886 |
[CC] GO:0030054 |
cell junction
|
ACHE, AKR1B1, APP, CHRM1, CHRM2, CHRM3, CHRM5, EGFR, HCAR2, HSPA1A, KDR, KIT, PRKCD, TEK, TRPV1 |
2.06037 |
[CC] GO:0005783 |
None
|
ADORA1, APEX1, APP, BCL2, CA4, CYP19A1, CYP2D6, FLT3, HSPA1A, KDR, PRKCD, PTPN1, XDH |
2.0502 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, AKR1B10, ALOX15, ALOX5, ALPL, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CDC25B, CHRM1, CHRM3, CHRM5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DUSP3, EGFR, ERBB2, F10, F3, FLT3, FUT7, GLO1, HSD11B1, HSD17B1, HSD17B2, HSPA1A, IGF1R, INSR, KDR, KIT, MAOA, MET, MIF, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PRKCD, PTGES, PTPN1, SRC, TBXAS1, TEK, TOP2A, TYR, XDH |
16.8962 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
16.4054 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX15, ALOX5, APP, CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, GLO1, MMP1, MMP12, MMP2, MMP9, PIM1, PPARA, PTPN1, RORC, SMAD3, TBXAS1, TYR, XDH |
14.7304 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, AXL, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTGES, PTPN1, RORC, SMAD3, SRC, TBXAS1, TEK, TOP2A, TRPV1, TYR, XDH |
13.753 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, POLB |
11.8002 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9 |
10.3517 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
9.82485 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, POLB |
9.05221 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CHRM3, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, DRD3, F10, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTPN1, RORC, SMAD3, TBXAS1, TOP2A, TRPV1, TYR, XDH |
9.04789 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, TEK |
8.9885 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CHRM1, CHRM2, CHRM3, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6, DRD3, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PPARA, PRKCD, SRC, TEK, TOP2A, TRPV1 |
8.9885 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6 |
8.12088 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, PRKCD, SRC, TEK |
8.02738 |
[MF] GO:0046872 |
metal ion binding
|
ALOX15, ALOX5, ALPL, APEX1, APP, AURKB, CA1, CA12, CA14, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, F10, GLO1, KIT, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, POLA1, POLB, PPARA, PRKCD, PTPN1, RORC, SMAD3, TBXAS1, TOP2A, TRPV1, TYR, XDH |
7.6356 |
[MF] GO:0005506 |
iron ion binding
|
ALOX15, ALOX5, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, XDH |
7.48315 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, INSR, KDR, KIT |
7.24719 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, AKR1B10, ALOX15, ALOX5, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD11B1, HSD17B1, HSD17B2, MAOA, TBXAS1, TYR, XDH |
7.18421 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
7.0431 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
6.83343 |
[MF] GO:0016907 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
6.37738 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK, TRPV1 |
6.31042 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
5.99095 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, SRC, TBXAS1 |
5.75498 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1, MMP1, MMP12, MMP2, MMP9, PPARA, PTPN1, RORC, SMAD3 |
5.74469 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK, TRPV1 |
5.69671 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, TEK, TRPV1 |
5.69671 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
5.51437 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK, TRPV1 |
5.41748 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, TBXAS1, TYR |
5.39494 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, SMAD3, TEK, TRPV1 |
5.29168 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CHRM1, CHRM2, CHRM3, CHRM5, DRD3, EGFR, ERBB2, F3, FLT3, GPR35, HCAR2, IGF1R, INSR, KDR, KIT, MET, PPARA, RORC, TEK, TRPV1 |
5.19389 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2D6 |
5.19389 |
[MF] GO:0048037 |
cofactor binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP2D6, HSD17B1, POLA1, PTGES, SRC, TBXAS1, XDH |
4.67883 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.54935 |
[MF] GO:0016772 |
transferase activity, transferring phosphorus-containing groups
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, POLB, PRKCD, SRC, TEK |
4.48648 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP2D6 |
4.36647 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK |
4.10718 |
[MF] GO:0015464 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
3.97406 |
[MF] GO:0005057 |
signal transducer activity, downstream of receptor
|
ADRB1, EGFR, ERBB2, INSR, KDR, KIT, SMAD3 |
3.96958 |
[MF] GO:0042562 |
hormone binding
|
ACHE, CHRM3, EGFR, HSD17B1, IGF1R, INSR |
3.73759 |
[MF] GO:0019899 |
enzyme binding
|
ADRB1, APP, AURKB, BCL2, CDC25B, CYP1A1, CYP1A2, CYP2A6, DUSP3, EGFR, ERBB2, F3, HSPA1A, KIT, MET, MIF, POLA1, POLB, PPARA, PRKCD, PTPN1, SMAD3, SRC, TEK, TOP2A |
3.54654 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PIM1, PPARA, PTPN1, SMAD3, SRC |
3.42514 |
[MF] GO:0008227 |
None
|
ADRB1, CHRM1, CHRM2, CHRM3, CHRM5 |
3.38183 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, FLT3, IGF1R, INSR, KDR, MMP12, MMP9, PPARA, PTPN1, SMAD3, SRC |
3.24046 |
[MF] GO:0019902 |
phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PPARA, PTPN1, SMAD3 |
3.24046 |
[MF] GO:0004629 |
None
|
ADORA1, CHRM1, CHRM3, CHRM5 |
3.18185 |
[MF] GO:0043168 |
anion binding
|
ALOX15, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, F10, F3, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, PTGES, SRC, TEK, TOP2A, TRPV1, XDH |
3.17527 |
[MF] GO:0140096 |
catalytic activity, acting on a protein
|
AURKB, AXL, CDC25B, CSNK2A1, DUSP3, EGFR, ERBB2, F10, F3, FLT3, IGF1R, INSR, KDR, KIT, MET, MMP1, MMP12, MMP2, MMP9, NUAK1, PIM1, PRKCD, PTPN1, SRC, TEK |
3.03445 |
[MF] GO:0005524 |
ATP binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK, TOP2A, TRPV1 |
3.02346 |
[MF] GO:0043560 |
insulin receptor substrate binding
|
IGF1R, INSR, PRKCD |
3.02346 |
[MF] GO:0032559 |
adenyl ribonucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK, TOP2A, TRPV1 |
2.89692 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.87225 |
[MF] GO:0030554 |
adenyl nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK, TOP2A, TRPV1 |
2.86393 |
[MF] GO:0016788 |
None
|
ACHE, ADORA1, ALPL, APEX1, CA1, CA2, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, POLA1, PTPN1 |
2.86135 |
[MF] GO:0019838 |
growth factor binding
|
EGFR, ERBB2, IGF1R, INSR, KDR, TEK |
2.83588 |
[MF] GO:0099528 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5 |
2.82843 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2, XDH |
2.73871 |
[MF] GO:0042578 |
None
|
ADORA1, ALPL, APEX1, CDC25B, CHRM1, CHRM3, CHRM5, DUSP3, PTPN1 |
2.72832 |
[MF] GO:0036094 |
small molecule binding
|
ADORA1, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FABP3, FABP4, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, TOP2A, TRPV1, XDH |
2.6599 |
[MF] GO:0008081 |
None
|
ADORA1, APEX1, CHRM1, CHRM3, CHRM5 |
2.54041 |
[MF] GO:0000166 |
nucleotide binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, TOP2A, TRPV1, XDH |
2.46444 |
[MF] GO:1901265 |
nucleoside phosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSD17B1, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, TOP2A, TRPV1, XDH |
2.46286 |
[MF] GO:0030594 |
None
|
CHRM1, CHRM2, CHRM3, CHRM5, DRD3 |
2.23131 |
[MF] GO:0051425 |
None
|
APP, INSR |
2.2273 |
[MF] GO:0097367 |
carbohydrate derivative binding
|
ADORA1, APP, AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, POLA1, PRKCD, SRC, TEK, TOP2A, TRPV1 |
2.14192 |
[MF] GO:0019903 |
protein phosphatase binding
|
BCL2, EGFR, ERBB2, MET, PTPN1 |
2.10276 |
[MF] GO:0005518 |
collagen binding
|
ACHE, MMP12, MMP9, SMAD3 |
2.10232 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, APP, BCL2, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, KIT, MET, MIF, MMP9, SMAD3, TOP2A, TRPV1, TYR, XDH |
2.09577 |
[MF] GO:0016616 |
oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
AKR1B1, AKR1B10, HSD11B1, HSD17B1, HSD17B2 |
2.09113 |
[MF] GO:0043559 |
insulin binding
|
IGF1R, INSR |
2.05685 |
[MF] GO:0046934 |
phosphatidylinositol-4,5-bisphosphate 3-kinase activity
|
EGFR, ERBB2, KIT, MET |
2.0484 |
[MF] GO:0035639 |
purine ribonucleoside triphosphate binding
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, HSPA1A, IGF1R, INSR, KDR, KIT, MET, NUAK1, PIM1, PRKCD, SRC, TEK, TOP2A, TRPV1 |
2.02753 |
[MF] GO:0004435 |
None
|
CHRM1, CHRM3, CHRM5 |
2.01484 |
[MF] GO:0033764 |
steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor
|
HSD11B1, HSD17B1, HSD17B2 |
2.01484 |
[MF] GO:0017171 |
serine hydrolase activity
|
ACHE, F10, F3, MMP1, MMP12, MMP2, MMP9 |
2.00053 |